microdosing.glp 1 Microdosing GLP-1s: Does It Work? Risks and Benefits Exploring Microdosing GLP-1 Medications: Benefits

doi: 10.1161/CIRCULATIONAHA.122.061732

EGT, ergothioneine

Clinical studies show that patients who use Ozempic experience significant weight loss compared to those using a placebo

"I'm worried about compounded medication quality." It's the most common concern and a reasonable one with a specific answer available if you ask for it

The biggest difference is the indication

Key Takeaways: GLP-1 vs GIP Both are incretin hormones released by your intestines after eating GLP-1 primarily affects appetite, gastric emptying, and insulin secretion GIP influences insulin secretion, glucagon regulation, and fat metabolism Single GLP-1 agonists (semaglutide) produce 14.9% average weight loss Dual GLP-1/GIP agonists (tirzepatide) produce 22.5% average weight loss The dual action appears to create additive rather than merely overlapping effects Both receptor types play important roles in metabolic regulation Understanding the difference helps explain why tirzepatide shows superior results What Are Incretin Hormones